Assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trial

Abstract Background Postoperative nausea and vomiting (PONV) is a common side effect associated with general anesthesia. Both ondansetron and aprepitant been effectively used to prevent PONV. However, there is a disagreement of opinions regarding the superiority of these two drugs. This study aims t...

Full description

Bibliographic Details
Main Authors: Mostafa Alam, Alireza Shakeri, Ardeshir Khorsand, Karim Nasseri, Sadaf Nasseri
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-023-02371-y
_version_ 1797388150877716480
author Mostafa Alam
Alireza Shakeri
Ardeshir Khorsand
Karim Nasseri
Sadaf Nasseri
author_facet Mostafa Alam
Alireza Shakeri
Ardeshir Khorsand
Karim Nasseri
Sadaf Nasseri
author_sort Mostafa Alam
collection DOAJ
description Abstract Background Postoperative nausea and vomiting (PONV) is a common side effect associated with general anesthesia. Both ondansetron and aprepitant been effectively used to prevent PONV. However, there is a disagreement of opinions regarding the superiority of these two drugs. This study aims to compare the efficacy of aprepitant with ondansetron in preventing PONV following orthognathic surgeries. Methods In this double-blinded clinical trial, 80 patients scheduled for orthognathic surgery at Imam Hossein Hospital, Tehran, Iran, were randomly assigned to two groups. A standardized anesthesia protocol was used for all patients. The first group received a placebo capsule administered one hour before the surgical procedure along with 4 mg (2 ml) of ondansetron intravenously after anesthesia induction. The second group was given 80 mg aprepitant capsules one hour before the surgery, followed by an injection of 2 ml intravenous distilled water after anesthesia induction. The occurrence and severity of PONV, the amount of rescue medication required, and the complete response of patients assessed within 24 h after the surgery. Results There were no significant differences in demographic data between the two groups. Patients in the aprepitant group had a significantly lower incidence and severity of nausea (2.5% versus 27.5%), vomiting (5% versus 25%), and required fewer rescue medications (7.5% versus 62.5%) compared to the ondansetron group. Additionally, the aprepitant group showed a higher complete response rate (90% versus 67.5%) in the 0-2 and 12-24 postoperative hours. Conclusion According to the findings of this study, aprepitant has demonstrated a greater efficacy in preventing PONV following orthognathic surgery, when compared to ondansetron. Trial registration Iranian Registry of Clinical Trials (IRCT code: IRCT20211205053279N3), date of registration: 16/12/2022.
first_indexed 2024-03-08T22:35:38Z
format Article
id doaj.art-b1afa8fb05234579aa5d53ff0076407b
institution Directory Open Access Journal
issn 1471-2253
language English
last_indexed 2024-03-08T22:35:38Z
publishDate 2023-12-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj.art-b1afa8fb05234579aa5d53ff0076407b2023-12-17T12:28:07ZengBMCBMC Anesthesiology1471-22532023-12-012311810.1186/s12871-023-02371-yAssessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trialMostafa Alam0Alireza Shakeri1Ardeshir Khorsand2Karim Nasseri3Sadaf Nasseri4Department of Oral and Maxillofacial Surgery, School of Dentistry, Shahid Beheshti University of Medical SciencesDepartment of Anesthesiology, Shahid Beheshti University of Medical SciencesDepartment of Oral and Maxillofacial Surgery, School of Dentistry, Shahid Beheshti University of Medical SciencesDepartment of Anesthesiology, Faculty of Medicine, Kurdistan University of Medical SciencesResearch Institute of Dental Sciences-Shahid Beheshti University of Medical Sciences, School of Dentistry, Shahid Beheshti University of Medical SciencesAbstract Background Postoperative nausea and vomiting (PONV) is a common side effect associated with general anesthesia. Both ondansetron and aprepitant been effectively used to prevent PONV. However, there is a disagreement of opinions regarding the superiority of these two drugs. This study aims to compare the efficacy of aprepitant with ondansetron in preventing PONV following orthognathic surgeries. Methods In this double-blinded clinical trial, 80 patients scheduled for orthognathic surgery at Imam Hossein Hospital, Tehran, Iran, were randomly assigned to two groups. A standardized anesthesia protocol was used for all patients. The first group received a placebo capsule administered one hour before the surgical procedure along with 4 mg (2 ml) of ondansetron intravenously after anesthesia induction. The second group was given 80 mg aprepitant capsules one hour before the surgery, followed by an injection of 2 ml intravenous distilled water after anesthesia induction. The occurrence and severity of PONV, the amount of rescue medication required, and the complete response of patients assessed within 24 h after the surgery. Results There were no significant differences in demographic data between the two groups. Patients in the aprepitant group had a significantly lower incidence and severity of nausea (2.5% versus 27.5%), vomiting (5% versus 25%), and required fewer rescue medications (7.5% versus 62.5%) compared to the ondansetron group. Additionally, the aprepitant group showed a higher complete response rate (90% versus 67.5%) in the 0-2 and 12-24 postoperative hours. Conclusion According to the findings of this study, aprepitant has demonstrated a greater efficacy in preventing PONV following orthognathic surgery, when compared to ondansetron. Trial registration Iranian Registry of Clinical Trials (IRCT code: IRCT20211205053279N3), date of registration: 16/12/2022.https://doi.org/10.1186/s12871-023-02371-yAprepitantOndansetronOrthognathic surgeryPostoperative nausea and vomiting
spellingShingle Mostafa Alam
Alireza Shakeri
Ardeshir Khorsand
Karim Nasseri
Sadaf Nasseri
Assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trial
BMC Anesthesiology
Aprepitant
Ondansetron
Orthognathic surgery
Postoperative nausea and vomiting
title Assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trial
title_full Assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trial
title_fullStr Assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trial
title_full_unstemmed Assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trial
title_short Assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trial
title_sort assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries a randomized controlled trial
topic Aprepitant
Ondansetron
Orthognathic surgery
Postoperative nausea and vomiting
url https://doi.org/10.1186/s12871-023-02371-y
work_keys_str_mv AT mostafaalam assessingtheimpactofaprepitantandondansetrononpostoperativenauseaandvomitinginorthognathicsurgeriesarandomizedcontrolledtrial
AT alirezashakeri assessingtheimpactofaprepitantandondansetrononpostoperativenauseaandvomitinginorthognathicsurgeriesarandomizedcontrolledtrial
AT ardeshirkhorsand assessingtheimpactofaprepitantandondansetrononpostoperativenauseaandvomitinginorthognathicsurgeriesarandomizedcontrolledtrial
AT karimnasseri assessingtheimpactofaprepitantandondansetrononpostoperativenauseaandvomitinginorthognathicsurgeriesarandomizedcontrolledtrial
AT sadafnasseri assessingtheimpactofaprepitantandondansetrononpostoperativenauseaandvomitinginorthognathicsurgeriesarandomizedcontrolledtrial